NDC 67457-593 – Arixtra

Fondaparinux Sodium 5 mg/.4mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC67457-593

Product details

Brand name
Arixtra
Generic name
Fondaparinux sodium
Labeler
Mylan Institutional LLC
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA021345
Marketed since
May 19, 2014
Listing expires
December 31, 2026
Pharmacologic class
Factor Xa Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Arixtra →

Package NDC codes (1)

Package NDCDescriptionSince
67457-593-0410 SYRINGE, GLASS in 1 CARTON (67457-593-04) / .4 mL in 1 SYRINGE, GLASS (67457-593-00)May 19, 2014

Other Arixtra products